ClinicalTrials.gov
ClinicalTrials.gov Menu

Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01397695
Recruitment Status : Unknown
Verified July 2011 by University of California, San Diego.
Recruitment status was:  Recruiting
First Posted : July 19, 2011
Last Update Posted : July 19, 2011
Sponsor:
Information provided by:
University of California, San Diego

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2014
  Estimated Study Completion Date : January 2014